Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors

British Journal of Cancer

Volumn 104, Issue 7, 2011, Pages 1185-1192

  Bijnsdorp, I V ^a   Capriotti, F ^a   Kruyt, F A E ^a,b   Losekoot, N ^a   Fukushima, M ^c   Griffioen, A W ^a   Thijssen, V L ^a   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

angiogenesis; deoxyribose; thymidine phosphorylase; thymidine phosphorylase inhibitor

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; INTERLEUKIN 8; MESSENGER RNA; PROTEIN P70; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INDUCING AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; FOCAL ADHESION KINASE 1; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; NEOPLASMS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953184249     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.74     Document Type: Article

References (46)

1. Ackland SP, Peters GJ (1999) Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs. Drug Resist Update 2: 205-214 (Pubitemid 29526244)
2. Bijman MN, Van Nieuw Amerongen GP, Laurens N, Van Hinsbergh VW, Boven E (2006) Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol Cancer Ther 5: 2348-2357 (Pubitemid 44530472)
3. Bijnsdorp IV, Azijli K, Jansen EE, Wamelink MM, Jakobs C, Struys EA, Fukushima M, Kruyt FAE, Peters GJ (2010a) Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells. Biochem Pharmacol 80: 786-792
4. Bijnsdorp IV, Vrijland K, Vroling L, Fukushima M, Peters GJ (2010b) Increased migration by stimulation of thymidine phosphorylase in endothelial cells of different origin. Nucleosides Nucleotides Nucleic Acids 29: 482-487
5. 0-O-tritylinosine (KIN59). Biochem Pharmacol 78: 231-240
6. Bronckaers A, Gago F, Balzarini J, Liekens S (2009b) The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev 29: 903-953
7. Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 334: 1-8 (Pubitemid 28420963)
8. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R (2000) Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 60: 6298-6302
9. Chiang GG, Abraham RT (2007) Targeting the mTOR signaling network in cancer. Trends Mol Med 13: 433-442 (Pubitemid 47570021)
10. De Bruin M, Peters GJ, Oerlemans R, Assaraf YG, Masterson AJ, Adema AD, Dijkmans BA, Pinedo HM, Jansen G (2004) Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cells. Mol Pharmacol 66: 1054-1060 (Pubitemid 39319478)
11. De Bruin M, Temmink OH, Hoekman K, Pinedo HM, Peters GJ (2006) Role of platelet derived endothelial cell growth factor/thymidine phosphor-ylase in health and disease. Cancer Ther 4: 99-124
12. De Bruin M, Van Capel T, Van der Born K, Kruyt FA, Fukushima M, Hoekman K, Pinedo HM, Peters GJ (2003) Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyr-imidine sensitivity. Br J Cancer 88: 957-964 (Pubitemid 36520887)
13. 0-deoxyribonu- cleosides. Biochem Pharmacol 59: 1227-1236 (Pubitemid 30157885)
14. Hayashi T, Kawahara H, Kobayashi S, Kashiwagi H, Hirai K, Yanaga K (2008) Importance of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase expression at the invasive front of T3 rectal cancer as prognostic factors. Hepatogastroenterology 55: 403-406 (Pubitemid 351741470)
15. Hotchkiss KA, Ashton AW, Schwartz EL (2003) Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3. J Biol Chem 278: 19272-19279 (Pubitemid 36799319)
16. Kubota Y, Miura T, Moriyama M, Noguchi S, Matsuzaki J, Takebayashi S, Hosaka M (1997) Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clin Cancer Res 3: 973-976 (Pubitemid 27252946)
17. Laurensse EJ, Pinedo HM, Peters GJ (1988) A sensitive non-radioactive assay for pyrimidine nucleoside phosphorylase using reversed-phase high performance liquid chromatography. Clin Chim Acta 178: 71-78
18. Lázár-Molnár E, Hegyesi H, Tóth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12: 547-554 (Pubitemid 30453481)
19. Liakakos T, Troupis T, Ghiconti I, Triantafyllidis S, Macheras A, Karatzas G, Pavlakis K (2006) Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells? Anticancer Res 26: 3899-3903 (Pubitemid 44701477)
20. Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J (2007) Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochem Pharmacol 74: 1555-1567 (Pubitemid 47614960)
21. Kidd EA, Yu J, Li X, Shannon WD, Watson MA, McLeod HL (2005) Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer. Clin Cancer Res 11: 2612-2619 (Pubitemid 40569461)
22. Mathews ST, Plaisance EP, Kim T (2009) Imaging systems for westerns: chemiluminescence vs infrared detection. Methods Mol Biol 536: 499-513
23. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5: 505-515 (Pubitemid 40942827)
24. Nagaoka H, Iino Y, Takei H, Morishita Y (1998) Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer. Int J Oncol 13: 449-454 (Pubitemid 28372665)
25. Nakajima Y, Gotanda T, Uchimiya H, Furukawa T, Haraguchi M, Ikeda R, Sumizawa T, Yoshida H, Akiyama S (2004) Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose. Cancer Res 64: 1794-1801 (Pubitemid 38428704)
26. Nakajima Y, Haraguchi M, Furukawa T, Yamamoto M, Nakanishi H, Tatematsu M, Akiyama S (2006) 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9. Int J Cancer 119: 1710-1716 (Pubitemid 44258781)
27. Nakajima Y, Madhyastha R, Maruyama M (2009) 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression. Anticancer Agents Med Chem 9: 239-245
28. Nakayama Y, Inoue Y, Nagashima N, Katsuki T, Matsumoto K, Kadowaki K, Shibao K, Tsurudome Y, Hirata K, Sako T, Nagata N, Itoh H (2005) Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer. Anticancer Res 25: 3755-3761 (Pubitemid 41658449)
29. O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R, Harris AL (1996) Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799-4804 (Pubitemid 26338087)
30. Pula G, Garonna E, Dunn WB, Hirano M, Pizzorno G, Campanella M, Schwartz EL, el Kouni MH, Wheeler-Jones CPD (2010) Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate. Arterioscler Thromb Vasc Biol 30(12): 2631-2638
31. Rosenkilde MM, Schwartz TW (2004) The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 112: 481-495 (Pubitemid 39626055)
32. Ruckhäberle E, Karn T, Engels K, Turley H, Hanker L, Müller V, Schmidt M, Ahr A, Gaetje R, Holtrich U, Kaufmann M, Rody A (2010) Prognostic impact of thymidine phosphorylase expression in breast cancer-Comparison of microarray and immunohistochemical data. Eur J Cancer 46: 549-557
33. Sakamoto H, Shirakawa T, Izuka S, Igarashi T, Kinoshita K, Ohtani K, Takami T, Nakayama Y, Teramoto K, Satoh K (1999) Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement. Gynecol Oncol 72: 298-305 (Pubitemid 29118185)
34. Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, Wagner C, Frank E, Jauch KW, Geissler EK (2004) Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy. Clin Cancer Res 10: 1843-1852 (Pubitemid 38435576)
35. Sengupta S, Sellers LA, Matheson HB, Fan TP (2003) Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol 139: 219-231 (Pubitemid 36760354)
36. Sivridis E, Giatromanolaki A, Anastasiadis P, Georgiou L, Gatter KC, Harris AL, Bicknell R, Koukourakis MI (2002) Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol 196: 416-422 (Pubitemid 34262853)
37. Stevenson DP, Milligan SR, Collins WP (1998) Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol 152: 1641-1646 (Pubitemid 28275022)
38. Szekanecz Z, Besenyei T, Paragh G, Koch AE (2009) Angiogenesis in rheumatoid arthritis. Autoimmunity 42: 563-573
39. Temmink OH, de Bruin M, Turksma AW, Cricca S, Laan AC, Peters GJ (2007) Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Int J Biochem Cell Biol 39: 565-575 (Pubitemid 46096794)
40. Thijssen VL, Brandwijk RJ, Dings RP, Griffioen AW (2004) Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp Cell Res 299: 286-293 (Pubitemid 39179797)
41. Thijssen VL, Hulsmans S, Griffioen AW (2008) The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 172: 545-553 (Pubitemid 351282039)
42. Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, Haraguchi M, Sumizawa T, Ono M, Kuwano M, Kanzaki T, Akiyama S (2002) Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Cancer Res 62: 2834-2839 (Pubitemid 34525768)
43. Wang X, Lin Y (2008) Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 29: 1275-1288
44. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M (1997) Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015-4023 (Pubitemid 27281877)
45. Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S, Noguchi Y (1999) Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer 79: 1145-1150 (Pubitemid 29087888)
46. Yu EJ, Lee Y, Rha SY, Kim TS, Chung HC, Oh BK, Yang WI, Noh SH, Jeung HC (2008) Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma. Mol Cancer Res 6: 1554-1566